CHEK2 encodes the checkpoint kinase 2 protein, and germline CHEK2 mutations have been associated moderately elevated risk for breast cancer, with an odds ratio of 2.7 for unselected breast cancer cases (Table 1) (109). This evidence concerns the gene CHEK2 and breast carcinoma.